Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Zyla Life Sciences (EGLT) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Zyla Life Sciences. Table 2 shows the detailed insider transactions. This company's CIK number is 1586105.
Total stock buying since 2014: $0.
Total stock sales since 2014: $4,539,184.
Total stock option exercises since 2014: $704,546.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2020 | 0 | $0 | 0 | $0 | 238,832 | $374,546 |
| 2019 | 0 | $0 | 300,000 | $750,000 | 132,000 | $330,000 |
| 2018 | 0 | $0 | 910 | $910 | 0 | $0 |
| 2017 | 0 | $0 | 61,233 | $274,931 | 0 | $0 |
| 2016 | 0 | $0 | 157,854 | $1,124,738 | 0 | $0 |
| 2015 | 0 | $0 | 112,988 | $1,231,456 | 0 | $0 |
| 2014 | 0 | $0 | 116,880 | $1,157,149 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2020-04 | 0 | $0 | 0 | $0 | 26,668 | $46,668 |
| 2020-03 | 0 | $0 | 0 | $0 | 212,164 | $327,878 |
| 2019-12 | 0 | $0 | 300,000 | $750,000 | 132,000 | $330,000 |
| 2018-01 | 0 | $0 | 910 | $910 | 0 | $0 |
| 2017-10 | 0 | $0 | 9,610 | $12,406 | 0 | $0 |
| 2017-07 | 0 | $0 | 5,196 | $12,244 | 0 | $0 |
| 2017-06 | 0 | $0 | 8,700 | $20,793 | 0 | $0 |
| 2017-04 | 0 | $0 | 9,419 | $47,479 | 0 | $0 |
| 2017-03 | 0 | $0 | 13,486 | $67,409 | 0 | $0 |
| 2017-01 | 0 | $0 | 14,822 | $114,600 | 0 | $0 |
| 2016-12 | 0 | $0 | 8,700 | $67,947 | 0 | $0 |
| 2016-10 | 0 | $0 | 29,286 | $218,838 | 0 | $0 |
| 2016-09 | 0 | $0 | 34,236 | $259,230 | 0 | $0 |
| 2016-07 | 0 | $0 | 28,480 | $143,322 | 0 | $0 |
| 2016-06 | 0 | $0 | 9,236 | $43,208 | 0 | $0 |
| 2016-04 | 0 | $0 | 19,340 | $135,014 | 0 | $0 |
| 2016-03 | 0 | $0 | 9,236 | $61,891 | 0 | $0 |
| 2016-01 | 0 | $0 | 19,340 | $195,288 | 0 | $0 |
| 2015-12 | 0 | $0 | 9,236 | $96,054 | 0 | $0 |
| 2015-10 | 0 | $0 | 24,876 | $303,146 | 0 | $0 |
| 2015-09 | 0 | $0 | 5,220 | $65,563 | 0 | $0 |
| 2015-07 | 0 | $0 | 37,920 | $479,437 | 0 | $0 |
| 2015-06 | 0 | $0 | 536 | $8,211 | 0 | $0 |
| 2015-04 | 0 | $0 | 14,610 | $164,710 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-04-23 | Smiley Andrea Heslin | Option Ex | 6,667 | 1.75 | 11,667 |
| 2020-04-23 | Mcinnis Joe | Option Ex | 6,667 | 1.75 | 11,667 |
| 2020-04-23 | Pauls Matthew | Option Ex | 6,667 | 1.75 | 11,667 |
| 2020-04-23 | Walbert Timothy P | Option Ex | 6,667 | 1.75 | 11,667 |
| 2020-03-26 | Timmins Megan C. (General Counsel) | Option Ex | 34,334 | 1.60 | 54,934 |
| 2020-03-26 | Strobeck Mark (Chief Operating Officer) | Option Ex | 62,000 | 1.60 | 99,200 |
| 2020-03-01 | Timmins Megan C. (General Counsel) | Option Ex | 40,095 | 1.50 | 60,142 |
| 2020-03-01 | Strobeck Mark (Chief Operating Officer) | Option Ex | 75,735 | 1.50 | 113,602 |
| 2019-12-31 | Radie Robert S (Principal Financial Officer) | Option Ex | 132,000 | 2.50 | 330,000 |
| 2019-12-30 | Shim James | Sale | 50,000 | 2.50 | 125,000 |
| 2019-12-23 | Shim James | Sale | 250,000 | 2.50 | 625,000 |
| 2018-01-02 | Shea Patrick M (Chief Commercial Officer) | Sale | 910 | 1.00 | 910 |
| 2017-10-02 | Shea Patrick M (Chief Commercial Officer) | Sale | 910 | 1.30 | 1,183 |
| 2017-10-02 | Strobeck Mark (Chief Operating Officer) | Sale | 8,700 | 1.29 | 11,223 |
| 2017-07-03 | Shea Patrick M (Chief Commercial Officer) | Sale | 910 | 2.35 | 2,138 |
| 2017-07-03 | Varki Paul (SVP, GC & Chief Compliance Officer) | Sale | 806 | 2.35 | 1,894 |
| 2017-07-03 | Musial Stan (Chief Financial Officer) | Sale | 3,480 | 2.36 | 8,212 |
| 2017-06-30 | Strobeck Mark (Chief Operating Officer) | Sale | 8,700 | 2.39 | 20,793 |
| 2017-04-03 | Varki Paul (SVP, GC & Chief Compliance Officer) | Sale | 806 | 5.05 | 4,070 |
| 2017-04-03 | Musial Stan (Chief Financial Officer) | Sale | 8,613 | 5.04 | 43,409 |
| 2017-03-31 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 536 | 5.16 | 2,765 |
| 2017-03-31 | Strobeck Mark (Chief Operating Officer) | Sale | 8,700 | 5.11 | 44,457 |
| 2017-03-20 | Shea Patrick M (Chief Commercial Officer) | Sale | 4,250 | 4.75 | 20,187 |
| 2017-01-03 | Varki Paul (SVP, GC & Chief Compliance Officer) | Sale | 806 | 7.75 | 6,246 |
| 2017-01-03 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 536 | 7.75 | 4,154 |
| 2017-01-03 | Musial Stan (Chief Financial Officer) | Sale | 13,480 | 7.73 | 104,200 |
| 2016-12-30 | Strobeck Mark (Chief Operating Officer) | Sale | 8,700 | 7.81 | 67,947 |
| 2016-10-03 | Varki Paul (SVP, GC & Chief Compliance Officer) | Sale | 806 | 7.56 | 6,093 |
| 2016-10-03 | Musial Stan (Chief Financial Officer) | Sale | 13,480 | 7.47 | 100,695 |
| 2016-10-03 | Radie Robert S (President and CEO) | Sale | 15,000 | 7.47 | 112,050 |
| 2016-09-30 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 536 | 7.69 | 4,121 |
| 2016-09-30 | Strobeck Mark (Chief Operating Officer) | Sale | 33,700 | 7.57 | 255,109 |
| 2016-07-06 | Radie Robert S (President and CEO) | Sale | 5,000 | 5.02 | 25,099 |
| 2016-07-05 | Musial Stan (Chief Financial Officer) | Sale | 3,480 | 5.05 | 17,574 |
| 2016-07-05 | Radie Robert S (President and CEO) | Sale | 5,000 | 4.94 | 24,700 |
| 2016-07-01 | Musial Stan (Chief Financial Officer) | Sale | 10,000 | 5.06 | 50,599 |
| 2016-07-01 | Radie Robert S (President and CEO) | Sale | 5,000 | 5.07 | 25,350 |
| 2016-06-30 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 536 | 4.65 | 2,492 |
| 2016-06-30 | Strobeck Mark (Chief Business Officer) | Sale | 8,700 | 4.68 | 40,716 |
| 2016-04-05 | Melloy Deanne F. (Chief Commercial Officer) | Sale | 860 | 6.96 | 5,985 |
| 2016-04-05 | Radie Robert S (President and CEO) | Sale | 5,000 | 6.99 | 34,950 |
| 2016-04-04 | Radie Robert S (President and CEO) | Sale | 5,000 | 6.99 | 34,950 |
| 2016-04-01 | Musial Stan (Chief Financial Officer) | Sale | 3,480 | 7.02 | 24,429 |
| 2016-04-01 | Radie Robert S (President and CEO) | Sale | 5,000 | 6.94 | 34,700 |
| 2016-03-31 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 536 | 6.72 | 3,601 |
| 2016-03-31 | Strobeck Mark (Chief Business Officer) | Sale | 8,700 | 6.70 | 58,290 |
| 2016-01-11 | Radie Robert S (President and CEO) | Sale | 3,000 | 9.65 | 28,950 |
| 2016-01-08 | Radie Robert S (President and CEO) | Sale | 4,000 | 9.69 | 38,760 |
| 2016-01-07 | Radie Robert S (President and CEO) | Sale | 3,000 | 9.61 | 28,830 |
| 2016-01-06 | Radie Robert S (President and CEO) | Sale | 2,100 | 10.16 | 21,336 |
| 2016-01-05 | Radie Robert S (President and CEO) | Sale | 1,400 | 11.11 | 15,554 |
| 2016-01-04 | Melloy Deanne F. (Chief Commercial Officer) | Sale | 860 | 10.45 | 8,987 |
| 2016-01-04 | Musial Stan (Chief Financial Officer) | Sale | 3,480 | 10.68 | 37,166 |
| 2016-01-04 | Radie Robert S (President and CEO) | Sale | 1,500 | 10.47 | 15,705 |
| 2015-12-31 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 536 | 10.40 | 5,574 |
| 2015-12-31 | Strobeck Mark (Chief Business Officer) | Sale | 8,700 | 10.40 | 90,480 |
| 2015-10-26 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 536 | 8.96 | 4,802 |
| 2015-10-06 | Melloy Deanne F. (Chief Commercial Officer) | Sale | 860 | 11.42 | 9,821 |
| 2015-10-01 | Musial Stan (Chief Financial Officer) | Sale | 8,480 | 12.32 | 104,473 |
| 2015-10-01 | Radie Robert S (President and CEO) | Sale | 15,000 | 12.27 | 184,050 |
| 2015-09-30 | Strobeck Mark (Chief Business Officer) | Sale | 5,220 | 12.56 | 65,563 |
| 2015-07-13 | Melloy Deanne F. (Chief Commercial Officer) | Sale | 4,000 | 11.85 | 47,400 |
| 2015-07-08 | Radie Robert S (President and CEO) | Sale | 3,000 | 11.62 | 34,860 |
| 2015-07-07 | Radie Robert S (President and CEO) | Sale | 3,000 | 12.31 | 36,930 |
| 2015-07-06 | Radie Robert S (President and CEO) | Sale | 3,000 | 11.94 | 35,820 |
| 2015-07-02 | Radie Robert S (President and CEO) | Sale | 3,000 | 12.44 | 37,320 |
| 2015-07-01 | Strobeck Mark (Chief Business Officer) | Sale | 10,440 | 12.98 | 135,511 |
| 2015-07-01 | Musial Stan (Chief Financial Officer) | Sale | 8,480 | 13.20 | 111,936 |
| 2015-07-01 | Radie Robert S (President and CEO) | Sale | 3,000 | 13.22 | 39,660 |
| 2015-06-30 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 536 | 15.32 | 8,211 |
| 2015-04-01 | Musial Stan (Chief Financial Officer) | Sale | 3,480 | 11.35 | 39,498 |
| 2015-04-01 | Radie Robert S (President and CEO) | Sale | 11,130 | 11.25 | 125,212 |
| 2015-02-03 | Dayno Jeffrey M. (Chief Medical Officer) | Sale | 2,500 | 8.87 | 22,174 |
| 2015-01-02 | Strobeck Mark (Chief Business Officer) | Sale | 3,480 | 5.09 | 17,713 |
| 2015-01-02 | Musial Stan (Chief Financial Officer) | Sale | 3,480 | 5.05 | 17,574 |
| 2015-01-02 | Radie Robert S (President and CEO) | Sale | 11,130 | 5.11 | 56,874 |
| 2014-09-10 | Radie Robert S (President and CEO) | Sale | 20,020 | 9.68 | 193,793 |
| 2014-09-09 | Radie Robert S (President and CEO) | Sale | 20,020 | 9.54 | 190,990 |
| 2014-09-08 | Radie Robert S (President and CEO) | Sale | 19,000 | 9.66 | 183,540 |
| 2014-09-05 | Radie Robert S (President and CEO) | Sale | 30,000 | 9.79 | 293,700 |
| 2014-08-13 | Strobeck Mark (Chief Business Officer) | Sale | 2,635 | 9.15 | 24,110 |
| 2014-08-12 | Strobeck Mark (Chief Business Officer) | Sale | 2,500 | 9.26 | 23,150 |
| 2014-08-11 | Strobeck Mark (Chief Business Officer) | Sale | 3,300 | 10.16 | 33,528 |
| 2014-08-08 | Strobeck Mark (Chief Business Officer) | Sale | 2,400 | 10.45 | 25,080 |
| 2014-08-07 | Strobeck Mark (Chief Business Officer) | Sale | 1,200 | 10.90 | 13,080 |
| 2014-08-07 | Musial Stan (Chief Financial Officer) | Sale | 6,272 | 11.03 | 69,180 |
| 2014-08-06 | Strobeck Mark (Chief Business Officer) | Sale | 1,885 | 11.89 | 22,412 |
| 2014-08-06 | Musial Stan (Chief Financial Officer) | Sale | 7,648 | 11.06 | 84,586 |
Insider trading activities including stock purchases, stock sales, and option exercises of EGLT listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Zyla Life Sciences (symbol EGLT, CIK number 1586105) see the Securities and Exchange Commission (SEC) website.